Anzeige
Mehr »
Login
Dienstag, 30.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1C5AB | ISIN: KYG608371046 | Ticker-Symbol: MSK
Tradegate
26.04.24
11:00 Uhr
0,700 Euro
-0,050
-6,67 %
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
MICROPORT SCIENTIFIC CORPORATION Chart 1 Jahr
5-Tage-Chart
MICROPORT SCIENTIFIC CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
0,7300,76529.04.
0,7250,77029.04.
PR Newswire
595 Leser
Artikel bewerten:
(2)

Shanghai MicroPort Medbot (Group) Co., Ltd.: Spanning 7,000 km, Toumai has completed the world's first cross-border 5G ultra-remote simulated surgery verification, surprisingly impressive appearance in Arab Health

DUBAI, UAE, Feb. 2, 2024 /PRNewswire/ -- With its grand opening in Dubai on January 29, the 49th Arab Health would last until February 1, 2024. Shanghai MicroPort Medbot (Group) Co., Ltd. ("MedBot") attended the conference with their Toumai four-arm laparoscopic surgical robot (Toumai). During the exhibition, Toumai completed the world's first cross-border 5G ultra-remote simulated surgery verification, spanning nearly 7,000 kilometers from Shanghai, China to Dubai, United Arab Emirates. This achievement showcased the highly stable, reliable, and safe tele-surgical system of the Toumai. It drives the global development trend and industrial transformation of minimally invasive surgery, bringing new medical options to patients worldwide through continuous innovation.

During the exhibition, numerous local medical institution managers, as well as medical experts and scholars from all over the world, visited the booth. During the verification, the staff controlled the Toumai patient's cart at the Dubai booth through the surgeon console in Shanghai, performing precise and smooth surgical actions such as dissection, traction, clamping, cutting, and suturing. Despite the nearly 7,000 kilometers of distance, and using only a small 5G SIM card, the simulation surgery proceeded without any signal lag or operational delay. The various surgical actions were almost synchronous, and the communication between the two locations was smooth and well-coordinated.

On site, it was evident that the remote simulation surgery verification had clear visibility throughout the process, with stable operation of the robotic arms and flexible instruments. The cutting and suturing effects were indistinguishable from local surgeries. Even in a regular 5G network environment, the Toumai robot demonstrated its precise identification, accurate dissection, and meticulous resection capabilities, fully showcasing the system's stability, the precision of the robotic arms, and the dexterity of the instruments.

So far, Toumai has performed over 100 human clinical tele-surgeries in multiple departments, covering nearly 30 cities in China and connecting more than 30 hospitals. It has achieved a series of landmark records, including the farthest surgical distance exceeding 5,000 kilometers, more than 70 surgeries of level three and four complexity, over 10 consecutive surgeries, including multiple consecutive surgeries of level four complexity such as radical prostatectomy, and more than 15 records of the world's first tele-surgeries.

Cision View original content:https://www.prnewswire.co.uk/news-releases/spanning-7-000-km-toumai-tm-has-completed-the-worlds-first-cross-border-5g-ultra-remote-simulated-surgery-verification-surprisingly-impressive-appearance-in-arab-health-302051425.html

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2024 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.